Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSENEN | Q9NZ42 | 5/20 | 0.42 |
| ▸ | CTSK | P43235 | 5/20 | 0.41 |
| ▸ | CTSS | P25774 | 4/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.41 |
| ▸ | PSEN2 | P49810 | 4/20 | 0.41 |
| ▸ | APH1B | Q8WW43 | 4/20 | 0.41 |
| ▸ | NCSTN | Q92542 | 4/20 | 0.41 |
| ▸ | APH1A | Q96BI3 | 4/20 | 0.41 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CTSD | P07339 | 2/20 | 0.38 |
| ▸ | REN | P00797 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30539290 | 0.87 | PSENEN (0.55) | PSENENCTSKCTSSCTSLCTSB | |
| SCHEMBL2408132 | 0.85 | CTSK (0.55) | PSENENCTSKCTSSCTSLCTSB | |
| SCHEMBL2408130 | 0.85 | CTSK (0.55) | PSENENCTSKCTSSCTSLCTSB | |
| SCHEMBL9041907 | 0.84 | CTSS (0.43) | PSENENCTSKCTSSCTSLCTSB | |
| SCHEMBL26818317 | 0.84 | CTSS (0.43) | PSENENCTSKCTSSCTSLCTSB | |
| SCHEMBL9041191 | 0.84 | CTSS (0.43) | PSENENCTSKCTSSCTSLCTSB | |
| SCHEMBL3058483 | 0.83 | CTSK (0.41) | PSENENCTSKCTSSCTSLCTSB | |
| SCHEMBL10538884 | 0.83 | SMN1; SMN2 (0.41) | PSENENCTSKCTSSCTSLCTSB | |
| SCHEMBL5886445 | 0.82 | CTSK (0.46) | PSENENCTSKCTSSCTSLCTSB | |
| SCHEMBL22527163 | 0.82 | CTSK (0.46) | PSENENCTSKCTSSCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8637578-B2 | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | ISIS INNOVATION LIMITED (GB) | 2014-01-28 | — | — | US | disclosed |
| US-20070213506-A1 | Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins | ISIS INNOVATION LIMITED (GB) | 2007-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213506-A1 | Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins | SCLY, PTMS, TST | PSENEN 3293/4885CTSK 3243/4885CTSS 1881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.